Harbor Advisory Corp MA Sells 1,420 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Harbor Advisory Corp MA decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,105 shares of the exchange traded fund’s stock after selling 1,420 shares during the period. Harbor Advisory Corp MA’s holdings in SPDR S&P Biotech ETF were worth $2,711,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Weatherly Asset Management L. P. increased its holdings in shares of SPDR S&P Biotech ETF by 0.3% in the 4th quarter. Weatherly Asset Management L. P. now owns 157,945 shares of the exchange traded fund’s stock worth $14,225,000 after purchasing an additional 532 shares in the last quarter. Kingsview Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 60.3% in the 4th quarter. Kingsview Wealth Management LLC now owns 6,350 shares of the exchange traded fund’s stock worth $572,000 after purchasing an additional 2,388 shares in the last quarter. Clientfirst Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $284,000. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $29,000. Finally, Strategic Financial Concepts LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $2,447,000.

SPDR S&P Biotech ETF Trading Down 1.4 %

SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. The firm has a market cap of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a fifty day simple moving average of $92.23 and a two-hundred day simple moving average of $96.30. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.